BridgeMD
New treatment option for Lateral Epicondylitis
Official title Effect of Scapular Stabilization Exercises and ESWT in Patients With Lateral Epicondylitis
ClinicalTrials.gov ID: NCT07238413
What this study is testing
- What it's testing
- We aim to investigate the effects of adding scapular stabilization exercises to the extracorporeal shock wave therapy (ESWT) protocol in the treatment of lateral epicondylitis on pain, muscle strength, functional status, and quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Aged between 18 and 65 years.
- Diagnosed with lateral epicondylitis by a physician, with positive Mill's, Cozen's, or Thomsen tests.
- Experiencing pain and tenderness over and around the lateral epicondyle for at least 3 months, with symptoms exacerbated by resisted elbow extension...
- Willing to voluntarily participate in the study.
You likely can't join if
- Individuals with serious systemic or cardiovascular diseases that contraindicate exercise of the hand and upper extremity.
- Those diagnosed with upper extremity entrapment neuropathies.
- Patients with a diagnosis of malignancy.
- Individuals with open wounds on the hand or upper extremity.
- Pregnant women or those suspected of being pregnant.
- Patients who have received physiotherapy and/or injection treatments within the last 6 weeks.
See the full eligibility criteria
- Aged between 18 and 65 years.
- Diagnosed with lateral epicondylitis by a physician, with positive Mill's, Cozen's, or Thomsen tests.
- Experiencing pain and tenderness over and around the lateral epicondyle for at least 3 months, with symptoms exacerbated by resisted elbow extension, wrist extension, gripping, and supination.
- Willing to voluntarily participate in the study.
- Individuals with serious systemic or cardiovascular diseases that contraindicate exercise of the hand and upper extremity.
- Those diagnosed with upper extremity entrapment neuropathies.
- Patients with a diagnosis of malignancy.
- Individuals with open wounds on the hand or upper extremity.
- Pregnant women or those suspected of being pregnant.
- Patients who have received physiotherapy and/or injection treatments within the last 6 weeks.
- Patients with diabetes mellitus, rheumatologic diseases, or neurological disorders.
- Individuals who have undergone upper extremity surgery or had an upper extremity fracture within the last 6 months.
- Patients with coagulation disorders or those receiving anticoagulant therapy.
- Individuals with conditions causing degenerative changes in the hand and upper extremity.
- Patients diagnosed with carpal tunnel syndrome, cubital tunnel syndrome, thoracic outlet syndrome, medial epicondylitis, radiohumeral bursitis, or cervical disc pathology.
- Patients using analgesic or anti-inflammatory medications other than acetaminophen (paracetamol).
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.